A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber

NCT00848965 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Perennial
Allergic Rhinitis

Interventions

DRUG: Fluticasone propionate
DRUG: Placebo

Sponsor

GlaxoSmithKline